The objective of this study was to investigate whether hypertonic hyperosmolar primes solution (HHPS), with an osmolarity
of 2300 mOsmol/L, causes endothelial damage/loss.
We investigated the economic impact of the use of a flowable haemostatic agent (Floseal) compared with non-flowable oxidised regenerated cellulose (ORC) agent in primary elective cardiac surgeryfrom the perspective of the UK National Health Service (NHS).
